Skip to navigation Skip to content

Commercial R&D Funding Portfolio

Share

Commercial R&D Funding Portfolio



A selected list of National MS Society commercial funding projects according to research area are shown below.

Neuroprotection and Repair
New York University; Gli1
University College London; potassium channel modulator
Karyopharm Therapeutics; KPT-350
Centre for Mental Health and Addiction; GluR2/GAPDH
Bionure; BN201
MedaRed; 5B8 mAb

Modulating the Immune Response
Amplimmune; AMP110
Apitope; ATX-MS-1467
TG Therapeutics; TGR-1202

Stem-cell based therapeutics
Athersys; MultiStem

Diagnostics and Biomarkers
GE Healthcare; GE-180
DioGenix; MSPrecise

Symptoms Management
Canbex Therapeutics, VSN16R
Accera / University of Miami; Axona
Concert Pharmaceuticals; CTP-354

View a comprehensive list of all Fast Forward funded projects

Share